ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,443 | -47.8% | 1,114 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $23,840 | -47.1% | 1,114 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $45,050 | -23.9% | 1,114 | -12.5% | 0.00% | -33.3% |
| Q4 2022 | $59,220 | -10.3% | 1,273 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $66,031 | +9.7% | 1,273 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $60,175 | -33.6% | 1,273 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $90,612 | -77.6% | 1,273 | -76.5% | 0.00% | -40.0% |
| Q4 2021 | $404,709 | +31.6% | 5,412 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $307,456 | +31.5% | 5,412 | +1.9% | 0.00% | +33.3% |
| Q2 2021 | $233,781 | -10.8% | 5,312 | -0.0% | 0.00% | -25.0% |
| Q1 2021 | $262,037 | +17.1% | 5,313 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $223,677 | -8.0% | 5,313 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $243,229 | -26.3% | 5,313 | -19.2% | 0.00% | -33.3% |
| Q2 2020 | $330,131 | +13.0% | 6,575 | +15.7% | 0.01% | 0.0% |
| Q1 2020 | $292,225 | -13.6% | 5,682 | +3.8% | 0.01% | 0.0% |
| Q4 2019 | $338,184 | +2.8% | 5,474 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $328,878 | -28.8% | 5,474 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $461,896 | -11.7% | 5,474 | 0.0% | 0.01% | -11.1% |
| Q1 2019 | $522,876 | +34.9% | 5,474 | 0.0% | 0.01% | +12.5% |
| Q4 2018 | $387,723 | -17.1% | 5,474 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $467,808 | -99.9% | 5,474 | 0.0% | 0.01% | -20.0% |
| Q2 2018 | $634,437,000 | +56.8% | 5,474 | +9.4% | 0.01% | +66.7% |
| Q1 2018 | $404,712,000 | +137557.1% | 5,002 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $294,000 | -41.0% | 5,002 | -53.0% | 0.00% | +33.3% |
| Q3 2017 | $498,000 | +18.6% | 10,642 | -8.7% | 0.00% | 0.0% |
| Q2 2017 | $420,000 | +17.0% | 11,660 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $359,000 | -8.2% | 11,660 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $391,000 | +26.1% | 11,660 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $310,000 | +20.6% | 11,660 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $257,000 | -24.9% | 11,660 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $342,000 | -11.2% | 11,660 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $385,000 | -8.6% | 11,660 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $421,000 | -17.5% | 11,660 | +3.0% | 0.00% | -25.0% |
| Q2 2015 | $510,000 | +102.4% | 11,325 | +37.7% | 0.00% | +100.0% |
| Q1 2015 | $252,000 | -39.7% | 8,222 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $418,000 | +28.6% | 8,222 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $325,000 | -8.2% | 8,222 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $354,000 | – | 8,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |